Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kari Kendra

Clinical trials sponsored by Kari Kendra, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Immune cell attack: new combo therapy targets brain tumors in advanced melanoma Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Immune cell attack: new combo therapy targets brain tumors in advanced melanoma

Disease control Recruiting now

This study tests a new treatment for people with stage IV melanoma that has spread to the brain. It combines a chemotherapy drug (temozolomide) with specially grown immune cells (NK cells) from a healthy donor. The goal is to see if this combination is safe and can shrink brain t…

Phase 1/2 • Sponsor: Kari Kendra • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC